Ristow et al. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N. Engl. J. Med.

Rosmond et al. The Pro12Ala PPARgamma2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men. Diabetes Metab. Res. Rev.on aging and longevity. Am. J. Hum. Genet. ( ), Schneider, J., Kreuzer, J., Hamann, A., Nawroth, P.P., Dugi, K.A., The proline-alanine substitution in the peroxisome proliferator-activated receptor-gamma gene is associated with lower lipoprotein lipase activity in vivo. Diabetes ( ), Spiegelman, B.M., PPARg: adipogenic regulator and thiazolidinedione receptor. Diabetes, Thatcher, A.R., Kannisto, V., Vaupel, J.W., The Forces of Mortality at Age to , Odense Monographs on Population Aging, vol. Odense University Press. Valve, R., Sivenius, K., Miettinen, R., Pihlajamaki, J., Rissanen, A., Deeb, S.S., Auwerx, J., Uusitupa, M., Laakso, M., Two polymorphisms in the peroxisome proliferator-activated receptor-gene are associated with severe overweight among obese women. J. Clin. Endocrinol. Metab. ( ), Yashin, A.I., De Benedictis, G., Vaupel, J.W., Tan, Q., Andreev, K.F., Iachine, I.A., Bonafe`, M., De Luca, M., Valensin, S., Carotenuto, L., Franceschi, C., Genes, demography and life span: the contribution of demographic data and genetic studies on aging and longevity. Am. J. Hum. Genet. ( ), Yen, C.J., Beamer, B.A., Negri, C., Silver, K., Brown, K.A., Yarnall, D.P., Burns, D.K., Roth,J.Shauldiner,A.R., Molecular scanning of the human peroxisome proliferator-activated receptor gamma (PPAR gamma) gene in diabetic Caucasians: identification of a Pro-Ala PPAR gamma missense mutation. Biochem. Biophys. Res. Commun. ( ), Zietz, B., Barth, N., Spiegel, D., Schmitz, G., Scholmerich, J., Schaffler,A., A Pro-Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARgamma) is associated with higher levels of total cholesterol and LDL-cholesterol in male Caucasian type diabetes patients. Exp. Clin. Endocrinol. Diabetes ( ), M. Barbieri et al./Experimental Gerontology 39 (2004) 1095-1100 The organization, promoter analysis, and expression of the human PPARgamma gene. J. Biol. Chem. ( ), Franceschi, C., Motta, L., Valensin, S., Rapisarda, R., Franzone, A., Berardelli,Motta,Monti,D.,Bonafe`,M.,Ferrucci,L.,Deiana,L.,Pes,G.M.,Carru,C.,Desole,M.S.,Barbi,C.,Sartoni,G.,Gemelli,C.,Lescai,F.,Olivieri,F.,
Marchegiani,F.,Cardelli,M.,Cavallone,L.,Gueresi,P.,Cossarizza,A.,
Troiano,L.,Pini,G.,Sansoni,P.passeri,G.Lisa,R.Spazzafumo,L.,
Amadio,L.Giunta,S.Stecconi,R.Morresi,R.Viticchi,C.Mattace,R.,
De Benedictis, G., Baggio, G., Do men and women follow different trajectories to reach extreme longevity? Aging Clin. Exp. Res.( ), Gerkins,V.R.Ting,A.,Menck,H.T.,Casagrande,J.T.,Terasaki,P.I.,
Pike,M.C.,Henderson,B.E.,HLA heterozygosity as a genetic marker of long-term survival. J. Natl Cancer Inst. ( ), Hasstedt,S.J.,Ren,Q.-F.,Teng,K.,Elbein,S.C.,Effect of the peroxisome proliferator-activated receptor-Pro-Ala variant on obesity, glucose homeostasis, and blood pressure in members of familial Type diabetic kindreds. J. Clin. Endocrinol. Metab. ( ), Ho, W.L., Chang, J.W., Tseng, R.C., Chen, J.T., Chen, C.Y., Jou, Y.S., Wang, Y.C., Loss of heterozygosity at loci of candidate tumor suppressor genes in microdissected primary non-small cell lung cancer. Cancer Detect. Prev. ( ), Hsueh, W.A., Law, R., The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistanceOn Ageing and Longevity. Am. J. Hum. Genet. (), Yen, C.J., Beamer, B.A., Negri, C., Silver, K., Brown, K.A., Yarnall, D.P., Burns, D.K., Roth, J., Shuldiner, A.R. Molecular scanning of the human peroxisome proliferator-activated receptor gamma (PPAR gamma) gene in diabetic Caucasians: identification of a Pro-Ala PPAR gamma missense mutation. Biochem. Biophys. Res. Commun. (), Zietz, B., Barth, N., Spiegel, D., Schmitz, G., Scholmerich, J., Schaffler, A. A Pro-Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPAR gamma) is associated with higher levels of total cholesterol and LDL-cholesterol in male Caucasian type diabetes patients. Exp. Clin. Endocrinol. Diabetes ().